The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Friday, December 17, 2021
Merck announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion ...
read more
Friday, December 17, 2021
Senhwa Biosciences, Inc., a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, ...
read more
Thursday, December 16, 2021
Bristol Myers Squibb announced that Orencia® (abatacept) was approved by the FDA for the prophylaxis, or prevention, of acute graft versus host ...
read more
Thursday, December 16, 2021
Vaxart, Inc. plans to test the cross-reactivity of its oral tablet COVID-19 vaccine candidate against the Omicron SARS-CoV-2 variant in two different ...
read more
Thursday, December 16, 2021
ILC Dover, Inc., a designer and manufacturer of high-performance materials for life critical and primarily life sciences-based applications, announced...
read more
Thursday, December 16, 2021
AstraZeneca’s Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody combination for the prevention of COVID-19, retained ...
read more
Wednesday, December 15, 2021
Kaiser Permanente research in Southern California published Nov. 25, 2021, in The Lancet Regional Health – Americas confirmed high Moderna COVID-19 ...
read more
Wednesday, December 15, 2021
CSL Behring announced that the European Medicines Agency (EMA) has granted its approval for an accelerated assessment request for etranacogene ...
read more
Wednesday, December 15, 2021
Merck announced that the European Commission (EC) has approved VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) for active immunization for the...
read more
Tuesday, December 14, 2021
Organon announced the completion of its acquisition of Forendo Pharma, a clinical-stage drug development company focused on novel treatments in women’...
read more
Tuesday, December 14, 2021
Merck announced that the FDA has placed clinical holds on the investigational new drug applications (INDs) for the oral and implant formulations of ...
read more
Tuesday, December 14, 2021
CSL Limited and Vifor Pharma Ltd, a global specialty pharmaceutical company with an emphasis in iron deficiency, nephrology & cardio-renal therapies ...
read more
Monday, December 13, 2021
Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company and Foghorn Therapeutics Inc. announced a strategic collaboration to...
read more
Friday, December 10, 2021
UCB announced positive topline results from the Phase 3 MycarinG study1 evaluating rozanolixizumab, a subcutaneously (SC) infused monoclonal antibody ...
read more
Friday, December 10, 2021
Eli Lilly and Company and Regor Therapeutics Group have entered into a multi-year research collaboration and licensing agreement to discover, develop ...
read more